Literature DB >> 12075578

The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia.

B Fruehwald-Schultes1, K M Oltmanns, W Kern, J Born, H L Fehm, A Peters.   

Abstract

OBJECTIVE: Insulin is thought to be an important regulator of leptin secretion. However, increasing evidence suggests that insulin-mediated glucose uptake rather than insulin per se regulates circulating leptin concentration. Here, we hypothesised that a reduction of insulin sensitivity, ie insulin resistance, will diminish the stimulatory effect of insulin on leptin secretion as a consequence of decreased insulin-mediated glucose uptake.
DESIGN: Changes in serum leptin concentration during 30 hyperinsulinaemic-hypoglycaemic clamps were studied after induction of different levels of insulin resistance in normal-weight men. In 15 subjects insulin sensitivity was reduced by exposing them to a 2.5 h antecedent hypoglycaemia (3.1 mmol/l) induced by a high rate of insulin infusion (15.0 mU/min/kg) on the day before the proper experiment ('ante-hypo' condition). In the other 15 subjects no antecedent hypoglycaemia was induced ('control' condition). The proper experiment on both conditions was a 6 h stepwise hypoglycaemic clamp induced by a constant rate of insulin infusion (1.5 mU/min/kg).
SUBJECTS: Experiments were carried out in 30 lean healthy subjects (age, mean +/- s.e.m., 26 +/- 1 y; body mass index, 23.1 +/- 0.6 kg/m2).
RESULTS: As expected, glucose demand during the clamp was lower in the ante-hypo condition than in the control condition (gram of glucose infused per kilogram body weight, 1.52 +/- 0.16 vs 2.01 +/- 0.17 g/kg; P < 0.05). During the clamp, leptin levels increased by 25.4 +/- 4.3% in the control condition (P < 0.05), but not in the ante-hypo condition (+4.8 +/- 4.5%; P > 0.25). Thus, serum leptin response to the clamp significantly differed between the two conditions (P < 0.01). Across both conditions, the increase of leptin levels during the clamp was correlated with the amount of glucose infused (r = 0.37; P < 0.05).
CONCLUSION: Considering that insulin concentrations were identical during both clamp conditions, the data indicate that experimentally-induced insulin resistance diminishes the stimulatory effect of insulin on leptin secretion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075578     DOI: 10.1038/sj.ijo.0801942

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  6 in total

1.  Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes.

Authors:  William Gibson; Jianhua Liu; Bruce Gaylinn; Michael O Thorner; Graydon S Meneilly; Sandra L Babich; David Thompson; Jean-Pierre Chanoine
Journal:  Metabolism       Date:  2009-12-16       Impact factor: 8.694

2.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

3.  Association of leptin and insulin resistance in PCOS: A case-controlled study.

Authors:  Bahia Namavar Jahromi; Mohammad Hassan Dabaghmanesh; Mohammad Ebrahim Parsanezhad; Faranak Fatehpoor
Journal:  Int J Reprod Biomed       Date:  2017-07

4.  Association of Serum Leptin with Anthropometric Indices of Obesity, Blood Lipids, Steroidal Hormones, and Insulin Resistance in Polycystic Ovarian Syndrome.

Authors:  Manjulata Kumawat; Priyanka Choudhary; Sameer Aggarwal
Journal:  J Hum Reprod Sci       Date:  2021-09-02

5.  Short Hypoxia Does not Affect Plasma Leptin in Healthy Men under Euglycemic Clamp Conditions.

Authors:  Andre Schmoller; Michaela Voss; Hartmut Gehring; Sebastian Rudolf; Ulrich Schweiger; Bernd Schultes; Kerstin M Oltmanns
Journal:  Int J Endocrinol       Date:  2009-06-01       Impact factor: 3.257

6.  Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.

Authors:  Manfred Hallschmid; Kamila Jauch-Chara; Oliver Korn; Matthias Mölle; Björn Rasch; Jan Born; Bernd Schultes; Werner Kern
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.